Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

obiltoxaximab MeSH Supplementary Concept Data 2026


MeSH Supplementary
obiltoxaximab
Unique ID
C000611266
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000611266
Entry Term(s)
Anthim
ETI-204
Registry Numbers
29Z5DNL48C
0
Heading Mapped to
*Antibodies, Monoclonal
*Antitoxins
Frequency
14
Note
A monoclonal antibody that neutralizes toxins produced by BACILLUS ANTHRACIS. It is used to treat inhalational ANTHRAX.
Source
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5796-805
Date Introduced
2017/01/01
Last Updated
2019/10/31
obiltoxaximab Preferred
ETI-204 Narrower
Anthim Narrower
page delivered in 0.006s